Véronique Debien
- Oncology top 10%
- HER2/EGFR in Cancer Research 11
- Cancer Treatment and Pharmacology 9
- Cancer Immunotherapy and Biomarkers 8
- Cancer Research top 10%
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 3
-
- Advanced Breast Cancer Therapies 5
-
- Bladder and Urothelial Cancer Treatments 4
-
- Chronic Lymphocytic Leukemia Research 2
Véronique Debien
25 papers receiving 560 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 406
- Cancer Research 183
- Radiology, Nuclear Medicine and Imaging 121
- Pulmonary and Respiratory Medicine 156
- Immunology 91
Countries citing papers authored by Véronique Debien
This map shows the geographic impact of Véronique Debien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Debien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Debien more than expected).
Fields of papers citing papers by Véronique Debien
This network shows the impact of papers produced by Véronique Debien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Debien. The network helps show where Véronique Debien may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Véronique Debien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 33 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 9 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 13 | |
| 19 | 2021 | 19 | |
| 20 | 2019 | 22 |
About Véronique Debien
Véronique Debien is a scholar working on Oncology, Cancer Research and Genetics, having authored 29 papers that have together received 564 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Genomics and Diagnostics (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (406 citations), Cancer Research (183 citations) and Radiology, Nuclear Medicine and Imaging (121 citations). Véronique Debien has collaborated with scholars based in Belgium, France and Italy. Frequent co-authors include Martine Piccart, Evandro de Azambuja, Laurence Buisseret, Alex De Caluwé, Xiaoxiao Wang, Vincent K. Tuohy, Emanuela Romano, Elisa Agostinetto, Christos Sotiriou and Philippe Aftimos. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.